Kute Vivek B, Tullius Stefan G, Rane Hemant, Chauhan Sanshriti, Mishra Vineet, Meshram Hari Shankar
Department of Nephrology and Clinical Transplantation, Institute of Kidney Diseases and Research Centre, Dr HL Trivedi Institute of Transplantation Sciences, Ahmedabad, India.
Division of Transplant Surgery and Transplant Surgery Research Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
Transplant Proc. 2022 Jul-Aug;54(6):1412-1416. doi: 10.1016/j.transproceed.2022.02.009. Epub 2022 Feb 10.
COVID-19 has drastically affected transplant services, but there is limited understanding of the discrepancy of COVID-19 effects on various regions of the world.
We have explored the Global Observatory for Organ Donation and Transplantation data for assessing the transplant number changes between the calendar year 2019 (n = 157,301) and 2020 (129,681).
There was a disproportionate impact of COVID-19 on different areas of the world. Globally, there was a decline of 17.5%, in which deceased donation, kidney (20.9%), pancreas (16.2%), lung (12.7%), liver (11.3%), and heart (8%) transplant declined disproportionally in different regions of the world. The pandemic affected almost all geographic regions and nations, but China and the United States were mostly able to recover from the initial halt of the transplant practices by the pandemic so that there was a cumulative increase in transplant numbers.
Our data show that developing nations lagged behind, whereas developed nations have been able to recover their transplantation programs during the pandemic. Further policy making and preparedness is required to safeguard the most vulnerable areas of the world to minimize the impact of any future pandemic on transplantation practices.
新型冠状病毒肺炎（COVID-19）对移植服务产生了巨大影响，但对于COVID-19对世界不同地区影响的差异了解有限。
我们探索了全球器官捐献与移植观察站的数据，以评估2019年（n = 157,301例）和2020年（129,681例）历年之间移植数量的变化。
COVID-19对世界不同地区产生了不均衡的影响。在全球范围内，移植数量下降了17.5%，其中脑死亡器官捐献、肾脏（20.9%）、胰腺（16.2%）、肺（12.7%）、肝脏（11.3%）和心脏（8%）移植在世界不同地区下降比例不均衡。疫情几乎影响了所有地理区域和国家，但中国和美国大多能够从疫情导致的移植业务最初停滞中恢复过来，从而使移植数量有所累积增加。
我们的数据表明，发展中国家滞后，而发达国家在疫情期间能够恢复其移植项目。需要进一步制定政策和做好准备，以保护世界上最脆弱的地区，尽量减少未来任何疫情对移植业务的影响。
